These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CFC transition: the emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirements. Everard ML Thorax; 2000 Oct; 55(10):811-4. PubMed ID: 10992529 [No Abstract] [Full Text] [Related]
3. Clinical inquiries. Are inhalers with spacers better than nebulizers for children with asthma? Hsu JT; Parker S; Hoekzema G J Fam Pract; 2004 Jan; 53(1):55-7. PubMed ID: 14709269 [No Abstract] [Full Text] [Related]
5. The change to non-CFC metered dose inhalers. Rubinfeld A Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296 [TBL] [Abstract][Full Text] [Related]
6. Selecting inhaler devices for children with asthma. Roberts J Prof Care Mother Child; 1997; 7(2):43-6. PubMed ID: 9220830 [No Abstract] [Full Text] [Related]
7. Managing the transition to CFC-free inhalers. Fehrenbach C Prof Nurse; 2000 Jan; 15(4):248-50. PubMed ID: 10983140 [TBL] [Abstract][Full Text] [Related]
9. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. Ross DL; Gabrio BJ J Aerosol Med; 1999; 12(3):151-60. PubMed ID: 10623331 [TBL] [Abstract][Full Text] [Related]
10. Inhalation devices--which is best for your patient? Yule H Hosp Pharm; 1992 Nov; 27(11):1010-2, 1015. PubMed ID: 10122038 [No Abstract] [Full Text] [Related]
11. Are metered-dose inhalers with holding chambers better than nebulizers for treating acute asthma? Epling J; Chang MH Am Fam Physician; 2003 Jan; 67(1):62-4. PubMed ID: 12537167 [No Abstract] [Full Text] [Related]
12. The ideal inhaler for asthma therapy. Buck H Med Device Technol; 2001 Sep; 12(7):24-7. PubMed ID: 12938556 [TBL] [Abstract][Full Text] [Related]
13. Easing the transition to CFC-free inhalers. Legge A Community Nurse; 1999 Dec; 5(11):19-20. PubMed ID: 11189650 [No Abstract] [Full Text] [Related]
14. [Position paper to the aut idem substitution obligation on inhalators]. ; ; ; Pneumologie; 2015 Apr; 69(4):196-8. PubMed ID: 25853268 [No Abstract] [Full Text] [Related]
15. Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers. Hughes DA; Woodcock A; Walley T Thorax; 1999 Dec; 54(12):1087-92. PubMed ID: 10567628 [TBL] [Abstract][Full Text] [Related]
16. [Inhalation therapy in children younger than 2 years. II. The practice]. Griffioen RW; de Jongh FH Ned Tijdschr Geneeskd; 1998 Jun; 142(26):1488-93. PubMed ID: 9752067 [TBL] [Abstract][Full Text] [Related]
17. Nebuliser systems for drug delivery in cystic fibrosis. Daniels T J Evid Based Med; 2013 Aug; 6(3):201. PubMed ID: 24325379 [No Abstract] [Full Text] [Related]
18. Inhaler devices for patients with asthma. Fitzmaurice D; Salter R Br J Gen Pract; 1996 Mar; 46(404):199-200. PubMed ID: 8731631 [No Abstract] [Full Text] [Related]
19. Building a case for evidence-based practice: inhalers vs. nebulizers. Melnyk BM Pediatr Nurs; 1999; 25(1):102-3, 101. PubMed ID: 10335257 [No Abstract] [Full Text] [Related]
20. AARC clinical practice guideline. Selection of aerosol delivery device. American Association for Respiratory Care. Respir Care; 1992 Aug; 37(8):891-7. PubMed ID: 10145780 [No Abstract] [Full Text] [Related] [Next] [New Search]